本页面由Tiger Trade Technology Pte. Ltd.提供服务

Revolution Medicines, Inc.

190.25
-3.7000-1.91%
成交量:113.73万
成交额:2.18亿
市值:407.78亿
市盈率:-21.33
高:193.61
开:191.57
低:189.40
收:193.95
52周最高:224.31
52周最低:47.45
股本:2.14亿
流通股本:1.85亿
量比:0.79
换手率:0.61%
股息:- -
股息率:- -
每股收益(TTM):-8.9212
每股收益(LYR):-5.9502
净资产收益率:-79.09%
总资产收益率:-30.12%
市净率:15.65
市盈率(LYR):-31.97

数据加载中...

2024/10/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/07

重要事件披露

Form 8-K - Current report
2024/08/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities